Who Should Not Take Mounjaro? Contraindications, Cautions and the Thyroid Question
Do not take Mounjaro if you or a close family member has had medullary thyroid carcinoma or MEN 2, if you are pregnant or planning pregnancy, or if you have had an allergic reaction to tirzepatide. Ordinary hypothyroidism on levothyroxine is not the thyroid warning, and most people with it can take Mounjaro.
ALTRcare Medical Team
Clinical Editorial
You should not take Mounjaro (tirzepatide) if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2), if you are pregnant or planning a pregnancy, or if you have had a serious allergic reaction to tirzepatide. A second group of conditions (pancreatitis, gallbladder disease, severe stomach or bowel disease, diabetic retinopathy) does not rule it out but needs a doctor's careful judgement first.
The question we hear most is about thyroid. Here is the short answer: common hypothyroidism, the kind treated with a daily levothyroxine tablet, is not the thyroid warning on the Mounjaro label. That warning is about one rare cancer. Details below.
Key takeaways
- Do not use: personal or family history of MTC or MEN 2, pregnancy or planning pregnancy, known allergy to tirzepatide.
- Use with caution: past pancreatitis, gallbladder disease, severe GI disease such as gastroparesis, diabetic retinopathy.
- Hypothyroidism on levothyroxine, Hashimoto's, and most thyroid nodules are not the MTC warning. Tell the doctor your exact diagnosis.
- Oral contraceptive pills can be less reliable for 4 weeks after starting and after each dose increase. Use a backup method.
- ALTRcare doctors do not change your thyroid or BP medicines. Those stay with your own doctor.
Absolute contraindications: when the answer is no
- Personal or family history of medullary thyroid carcinoma (MTC). In rodent studies, tirzepatide caused thyroid C-cell tumours. Whether this happens in humans is not known, but because MTC is serious, anyone with a personal history, or a parent, sibling or child who had it, should not take Mounjaro.
- MEN 2 (Multiple Endocrine Neoplasia syndrome type 2). A rare inherited condition that carries a high risk of MTC. Same exclusion.
- Pregnancy, or planning a pregnancy. Mounjaro is not used in pregnancy. It is stopped well before trying to conceive; your doctor advises how long. If you become pregnant while on it, stop and call your doctor.
- Known hypersensitivity to tirzepatide or any ingredient of the pen, such as a previous serious allergic reaction.
Breastfeeding is also a situation where doctors generally do not start Mounjaro, because there is too little safety data.
Is Mounjaro safe for thyroid patients?
For most thyroid patients, yes. Thyroid problems are very common in India, and almost all of them are not what the Mounjaro warning is about. The warning is specific to medullary thyroid carcinoma, a rare cancer of the thyroid's C-cells, and MEN 2, the inherited syndrome that causes it.
| Your thyroid history | Is it the Mounjaro warning? | What to do |
|---|---|---|
| Hypothyroidism on levothyroxine (Thyronorm, Eltroxin and similar) | No | Usually fine to take Mounjaro. Keep taking your thyroid tablet as your own doctor prescribes. |
| Hashimoto's thyroiditis | No | Usually fine. Mention it at the consultation. |
| Hyperthyroidism, now treated | No | Discuss with the doctor; your own doctor keeps managing it. |
| Goitre or thyroid nodules | Not in itself | Share any ultrasound or biopsy reports so the doctor can confirm. |
| Papillary or follicular thyroid cancer, treated | Not the specific MTC warning | Needs individual review; bring your oncologist's notes. |
| Medullary thyroid carcinoma, you or close family | Yes | Do not take Mounjaro. |
| MEN 2, you or close family | Yes | Do not take Mounjaro. |
Mounjaro and hypothyroidism: what actually changes
You keep taking levothyroxine as usual, on an empty stomach as your doctor advised. Mounjaro slows stomach emptying, which can affect how some tablets are absorbed, and as you lose weight the thyroid dose you need can change. So your own doctor may want to recheck your TSH after a few months. ALTRcare doctors do not change your thyroid medicine. That stays with the doctor who prescribes it; we simply need to know what you take.
Caution flags: conditions that need a closer look
These do not automatically rule Mounjaro out. They change the risk, and a responsible doctor asks about every one before prescribing. The full list for all GLP-1 medicines is in our GLP-1 contraindications guide.
| Condition | Why it matters |
|---|---|
| Past pancreatitis | GLP-1 medicines have been linked with rare pancreatitis. The cause and timing of your episode decide whether it is reasonable. |
| Gallbladder disease or gallstones | Fast weight loss raises gallstone risk, and these medicines add to it. See our gallbladder guide. |
| Severe GI disease, including gastroparesis | Tirzepatide slows stomach emptying and can make existing slow-stomach symptoms much worse. |
| Diabetic retinopathy | A rapid fall in blood sugar can temporarily worsen existing eye disease, so your eye status matters. |
| Type 2 diabetes on insulin or sulfonylureas (glimepiride, gliclazide) | Risk of low blood sugar. Your diabetes doctor may need to reduce those doses. |
| Kidney disease | Vomiting or diarrhoea can dehydrate you and strain weak kidneys. |
| Type 1 diabetes | Mounjaro is not a substitute for insulin and is not approved for type 1 diabetes. |
| Past eating disorder | Appetite-suppressing medication needs specialist judgement here. |
Women on the pill
Oral contraceptives can be less reliable for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase. Use a backup method such as condoms in those windows, or discuss a non-oral method with your gynaecologist.
Not sure if any of this applies to you?
The free consultation exists for exactly this. A senior specialist goes through your history and reports and tells you plainly whether Mounjaro is safe for you.
Blood pressure and other long-term medicines
Most BP, cholesterol and thyroid medicines can be taken alongside Mounjaro. As weight comes off, blood pressure often falls, and some people on BP tablets notice dizziness when standing. If that happens, tell your own doctor, who may adjust the dose. ALTRcare doctors manage the weight-loss programme only; they do not change your thyroid, BP or other chronic medicines. Those decisions stay with the doctor who knows your full history. Bring a list of everything you take to the consultation, including ayurvedic or herbal products.
Why the screening questions exist
Every question at a proper Mounjaro consultation maps to this page: your thyroid history, your family's thyroid history, past pancreatitis or gallstones, stomach problems, eyes if you have diabetes, pregnancy plans, and every medicine you take. If a pharmacy or website sells you tirzepatide without asking these, nobody has screened you. The blood tests guide explains which reports help the doctor decide.
At ALTRcare that screening is done by a senior specialist: Dr. Mujeeb Afzal (MD, DM Endocrinology), Dr. (Major) Bhavesh Talera (MD, MRCP (UK), FRCP, internal medicine), Dr. Archana Rathi (diabetologist, ex-Registrar Bombay Hospital, PCOS and women's health) or Dr. Snigdha Sehgal (MD Internal Medicine). The free online doctor consultation is a 15–20 minute video call, and if the doctor says Mounjaro is not right for you, you hear it plainly. If you bought a plan first, it is refunded in full.
If you are cleared, the tirzepatide 3-month plan is ₹34,999 (₹11,666 a month) for all three doses (2.5 mg, 5 mg, 7.5 mg), with three doctor consultations timed to each dose step, a nutritionist and diet plan, WhatsApp side-effect support and cold-chain delivery, GST included. The medicine ships only after the doctor prescribes.
Find out if Mounjaro is safe for you
Take the 2-minute assessment and book a free video consultation with a senior specialist. Have your thyroid report and medicine list handy.
Mounjaro® is a registered trademark of Eli Lilly and Company. Yurpeak® is marketed in India by Cipla. ALTRcare is not affiliated with either company.
Frequently asked questions
Who should not take Mounjaro?
People with a personal or family history of medullary thyroid carcinoma or MEN 2, anyone pregnant or planning pregnancy, and anyone allergic to tirzepatide. Past pancreatitis, gallbladder disease, severe GI disease and diabetic retinopathy need careful doctor review first.
Can I take Mounjaro if I have hypothyroidism?
Usually yes. Hypothyroidism treated with levothyroxine is not the thyroid warning on the Mounjaro label, which is about medullary thyroid carcinoma and MEN 2. Keep taking your thyroid tablet, and your own doctor may recheck TSH as your weight changes.
Does Mounjaro cause thyroid cancer?
Tirzepatide caused thyroid C-cell tumours in rodents; whether it does so in humans is not known. As a precaution, people with a personal or family history of medullary thyroid carcinoma or MEN 2 should not take it.
Will ALTRcare change my thyroid or BP medicine?
No. ALTRcare doctors manage the weight-loss programme only. Your thyroid, BP and other long-term medicines stay with your own doctor, who may adjust them as your weight changes.
Can I take Mounjaro if I had gallstones or pancreatitis?
Not automatically ruled out, but both are genuine caution flags. The doctor will look at when it happened, the cause and your current health before deciding.
Ready to take the next step?
Take the free 2-minute eligibility assessment. A doctor reviews it before anything is prescribed, with no obligation.
This article is for general educational purposes and is not a substitute for personalised medical advice. GLP-1 medications are prescription-only and not suitable for everyone. Always consult a qualified doctor before starting, changing, or stopping any treatment.
